These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 26849376)
1. Expression of 58-kD Microspherule Protein (MSP58) is Highly Correlated with PET Imaging of Tumor Malignancy and Cell Proliferation in Glioma Patients. Lin W; Dai SH; Chen T; Kawai N; Miyake K; Okada M; Haba R; Yamamoto Y; Tamiya T; Fei Z Cell Physiol Biochem; 2016; 38(2):635-45. PubMed ID: 26849376 [TBL] [Abstract][Full Text] [Related]
2. Increased expression of the 58-kD microspherule protein (MSP58) is correlated with poor prognosis in glioma patients. Lin W; Li XM; Zhang J; Huang Y; Wang J; Zhang J; Jiang XF; Fei Z Med Oncol; 2013 Dec; 30(4):677. PubMed ID: 23996240 [TBL] [Abstract][Full Text] [Related]
4. Glioma proliferation as assessed by 3'-fluoro-3'-deoxy-L-thymidine positron emission tomography in patients with newly diagnosed high-grade glioma. Ullrich R; Backes H; Li H; Kracht L; Miletic H; Kesper K; Neumaier B; Heiss WD; Wienhard K; Jacobs AH Clin Cancer Res; 2008 Apr; 14(7):2049-55. PubMed ID: 18381944 [TBL] [Abstract][Full Text] [Related]
5. Increased Expression of 58-kDa Microspherule Protein (MSP58) in Human Gastric Cancer Promotes Cell Proliferation and Correlates with Poor Patient Survival. Cui J; Xi H; Cai A; Ma L; Bian S; Zhang K; Wei B; Chen L Clin Lab; 2016; 62(6):993-1001. PubMed ID: 27468560 [TBL] [Abstract][Full Text] [Related]
6. 18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors. Jacobs AH; Thomas A; Kracht LW; Li H; Dittmar C; Garlip G; Galldiks N; Klein JC; Sobesky J; Hilker R; Vollmar S; Herholz K; Wienhard K; Heiss WD J Nucl Med; 2005 Dec; 46(12):1948-58. PubMed ID: 16330557 [TBL] [Abstract][Full Text] [Related]
7. 11C-methionine (MET) and 18F-fluorothymidine (FLT) PET in patients with newly diagnosed glioma. Hatakeyama T; Kawai N; Nishiyama Y; Yamamoto Y; Sasakawa Y; Ichikawa T; Tamiya T Eur J Nucl Med Mol Imaging; 2008 Nov; 35(11):2009-17. PubMed ID: 18542957 [TBL] [Abstract][Full Text] [Related]
8. Noninvasive quantification of 18F-FLT human brain PET for the assessment of tumour proliferation in patients with high-grade glioma. Backes H; Ullrich R; Neumaier B; Kracht L; Wienhard K; Jacobs AH Eur J Nucl Med Mol Imaging; 2009 Dec; 36(12):1960-7. PubMed ID: 19672593 [TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of O-(2-[18F]-Fluoroethyl)-L-Tyrosine-Positron Emission Tomography Imaging for Histopathologic Characteristics and Progression-Free Survival in Patients with Low-Grade Glioma. Bette S; Gempt J; Delbridge C; Kirschke JS; Schlegel J; Foerster S; Huber T; Pyka T; Zimmer C; Meyer B; Ringel F World Neurosurg; 2016 May; 89():230-9. PubMed ID: 26855307 [TBL] [Abstract][Full Text] [Related]
11. Dynamic small-animal PET imaging of tumor proliferation with 3'-deoxy-3'-18F-fluorothymidine in a genetically engineered mouse model of high-grade gliomas. Bradbury MS; Hambardzumyan D; Zanzonico PB; Schwartz J; Cai S; Burnazi EM; Longo V; Larson SM; Holland EC J Nucl Med; 2008 Mar; 49(3):422-9. PubMed ID: 18287265 [TBL] [Abstract][Full Text] [Related]
12. RNAi-mediated inhibition of MSP58 decreases tumour growth, migration and invasion in a human glioma cell line. Lin W; Zhang J; Zhang J; Liu X; Fei Z; Li X; Davidovic L; Tang Z; Shen L; Deng Y; Yang A; Han H; Zhang X; Yao L J Cell Mol Med; 2009; 13(11-12):4608-22. PubMed ID: 18798870 [TBL] [Abstract][Full Text] [Related]
13. Correlation of 4'-[methyl-(11)C]-thiothymidine uptake with Ki-67 immunohistochemistry and tumor grade in patients with newly diagnosed gliomas in comparison with (11)C-methionine uptake. Tanaka K; Yamamoto Y; Maeda Y; Yamamoto H; Kudomi N; Kawai N; Toyohara J; Nishiyama Y Ann Nucl Med; 2016 Feb; 30(2):89-96. PubMed ID: 26511019 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of 3'-deoxy-3'-[18F]-fluorothymidine (18F-FLT) kinetics correlated with thymidine kinase-1 expression and cell proliferation in newly diagnosed gliomas. Shinomiya A; Kawai N; Okada M; Miyake K; Nakamura T; Kushida Y; Haba R; Kudomi N; Yamamoto Y; Tokuda M; Tamiya T Eur J Nucl Med Mol Imaging; 2013 Jan; 40(2):175-85. PubMed ID: 23229746 [TBL] [Abstract][Full Text] [Related]
15. [Use of 11F-fluorothymidine positron emission tomography in brain tumor]. Kawai N; Kagawa M; Miyake K; Nishiyama Y; Yamamoto Y; Shiraishi H; Ichikawa T; Tamiya T No Shinkei Geka; 2009 Jul; 37(7):657-64. PubMed ID: 19621774 [TBL] [Abstract][Full Text] [Related]
17. Prognostic value of 3'-deoxy-3'-18F-fluorothymidine ([(18)F] FLT PET) in patients with recurrent malignant gliomas. Zhao F; Cui Y; Li M; Fu Z; Chen Z; Kong L; Yang G; Yu J Nucl Med Biol; 2014 Sep; 41(8):710-5. PubMed ID: 24929963 [TBL] [Abstract][Full Text] [Related]
18. Comparison of 4'-[methyl-(11)C]thiothymidine ((11)C-4DST) and 3'-deoxy-3'-[(18)F]fluorothymidine ((18)F-FLT) PET/CT in human brain glioma imaging. Toyota Y; Miyake K; Kawai N; Hatakeyama T; Yamamoto Y; Toyohara J; Nishiyama Y; Tamiya T EJNMMI Res; 2015; 5():7. PubMed ID: 25853013 [TBL] [Abstract][Full Text] [Related]
19. Imaging regional variation of cellular proliferation in gliomas using 3'-deoxy-3'-[18F]fluorothymidine positron-emission tomography: an image-guided biopsy study. Price SJ; Fryer TD; Cleij MC; Dean AF; Joseph J; Salvador R; Wang DD; Hutchinson PJ; Clark JC; Burnet NG; Pickard JD; Aigbirhio FI; Gillard JH Clin Radiol; 2009 Jan; 64(1):52-63. PubMed ID: 19070698 [TBL] [Abstract][Full Text] [Related]
20. [18F]3'-deoxy-3'-fluorothymidine PET for the diagnosis and grading of brain tumors. Choi SJ; Kim JS; Kim JH; Oh SJ; Lee JG; Kim CJ; Ra YS; Yeo JS; Ryu JS; Moon DH Eur J Nucl Med Mol Imaging; 2005 Jun; 32(6):653-9. PubMed ID: 15711980 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]